Eli Lilly & Co. (LLY), AstraZeneca (AZN) to Co-Develop MEDI181 for Alzheimer's
Tweet Send to a Friend
Eli Lilly and Company (NYSE: LLY) and AstraZeneca (NYSE: AZN) announced a worldwide agreement to co-develop MEDI1814, an antibody ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
